Research output per year
Research output per year
Fingerprint
Dive into the research topics where Hyuncheol Chung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis
Park, S., Nam, C. M., Kim, S. G., Mun, J. E., Rha, S. Y. & Chung, H. C., 2021 Feb, In: European Journal of Cancer. 144, p. 49-60 12 p.Research output: Contribution to journal › Review article › peer-review
-
Detection of asymptomatic recurrence improves survival of gastric cancer patients
Park, J. S., Choe, E. A., Park, S., Nam, C. M., Hyung, W. J., Noh, S. H., Lee, S., Kim, H. S., Jung, M., Chung, H. C. & Rha, S. Y., 2021 May, In: Cancer medicine. 10, 10, p. 3249-3260 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
So, J. B. Y., Kapoor, R., Zhu, F., Koh, C., Zhou, L., Zou, R., Tang, Y. C., Goo, P. C. K., Rha, S. Y., Chung, H. C., Yoong, J., Yap, C. T., Rao, J., Chia, C. K., Tsao, S., Shabbir, A., Lee, J., Lam, K. P., Hartman, M., Yong, W. P. & 2 others, , 2021 May 1, In: Gut. 70, 5, p. 829-837 9 p., 33028667.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Scopus) -
Efficacy of pembrolizumab monotherapy for advanced gastric/gastroesophageal junction cancer with programmed death ligand 1 combined positive score ≥10
Wainberg, Z. A., Fuchs, C. S., Tabernero, J., Shitara, K., Muro, K., Van Cutsem, E., Bang, Y. J., Chung, H. C., Yamaguchi, K., Varga, E., Chen, J. S., Hochhauser, D., Thuss-Patience, P., Al-Batran, S. E., Garrido, M., Kher, U., Shih, C. S., Shah, S., Bhagia, P. & Chao, J., 2021 Apr, In: Clinical Cancer Research. 27, 7, p. 1923-1931 9 p.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Chung, H. C., Bang, Y. J., S Fuchs, C., Qin, S. K., Satoh, T., Shitara, K., Tabernero, J., Cutsem, E. V., Alsina, M., Cao, Z. A., Lu, J., Bhagia, P., Shih, C. S. & Janjigian, Y. Y., 2021 Feb, In: Future Oncology. 17, 5, p. 491-501 11 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Scopus)